Site name unknown, Sao Paulo

Phase	Trial [desc]	Trial Status	Site Status	Drug	NCT#
2	Phase ll Study of Imatinib Mesylate for the Neoadjuvant Treatment of Patients With Gastrointestinal Stromal Tumors (GIST) (CONVERT)	Completed	Closed	Imatinib	NCT01483014
3	Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)	Completed	Closed	Nilotinib or Imatinib	NCT00785785
3	Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg (LANGIST)	Terminated	Closed	Nilotinib or Imatinib	NCT00751036